[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

US20040096932A1 - Enzyme catalysis in the presence of ionic liquids - Google Patents

Enzyme catalysis in the presence of ionic liquids Download PDF

Info

Publication number
US20040096932A1
US20040096932A1 US10/416,067 US41606704A US2004096932A1 US 20040096932 A1 US20040096932 A1 US 20040096932A1 US 41606704 A US41606704 A US 41606704A US 2004096932 A1 US2004096932 A1 US 2004096932A1
Authority
US
United States
Prior art keywords
aryl
alkyl
reaction medium
ionic liquid
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/416,067
Inventor
Udo Kragl
Nicole Kaftzik
Sonja Schofer
Peter Wasserscheid
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8170307&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20040096932(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Publication of US20040096932A1 publication Critical patent/US20040096932A1/en
Priority to US11/440,321 priority Critical patent/US20060211096A1/en
Priority to US12/119,214 priority patent/US7754462B2/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/004Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of alcohol- or thiol groups in the enantiomers or the inverse reaction
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/62Carboxylic acid esters

Definitions

  • the invention relates to compositions comprising an enzyme and ionic liquids as well as a method for carrying out enzyme-catalysed reactions in the presence of ionic liquids.
  • ionic liquids are melting salts which represent a new class of solvents having a non-molecular ionic character.
  • ionic liquids have no measurable vapour pressure. This is a major advantage from the process engineering point of view because in this way, the distillative separation of a reaction mixture is possible as an effective method for product separation.
  • Ionic liquids are temperature-stable up to above 200° C.
  • cation and anion it is possible to gradually adjust the polarity and thereby tune the solubility properties.
  • the range goes from water-miscible ionic liquids through water-immiscible ionic liquids as far as those which themselves form two phases with organic solvents.
  • the skilful utilization of the extraordinary solubility properties is the key to the successful use of ionic liquids as a new class of solvents.
  • Ionic liquids have already been successfully used as new types of media in two-phase catalysis or as the medium for liquid-liquid extraction). (P. Wasserscheid, W. Keim, Angew. Chem. 2000, 112, 3926).
  • ionic liquids can be used as co-solvents to improve the solubility of educts and products.
  • the invention relates to a method for the conversion of substances (educts) in the presence of enzymes as a catalyst in a reaction medium comprising ionic liquids.
  • the ionic liquid can be miscible with water or immiscible with water. In the same way, it is possible to carry out a single-phase, two-phase or multi-phase reaction.
  • the ionic liquids comprise compounds having the general formula
  • the anion [Y] n ⁇ is selected from the group comprising tetrafluoroborate ([BF 4 ] ⁇ ), tetrachloroborate ([BCl 4 ] ⁇ ), hexafluorophosphate ([PF 6 ] ⁇ ), hexafluoroantimonate ([SbF 6 ] ⁇ ), hexafluoroarsenate ([AsF 6 ] ⁇ ), tetrachloroaluminate ([AlCl 4 ] ⁇ ), trichlorozincate [(ZnCl 3 ] ⁇ ), dichlorocuprate, sulphate ([SO 4 ] 2 ⁇ ), carbonate ([CO 3 ] 2 ⁇ ), fluorosulphonate, [R′—COO] ⁇ , [R′—SO 3 ] ⁇ or [(R′—SO 2 ) 2 N] ⁇ , and R′ is a linear or branched aligonane
  • the imidizole nucleus can be substituted with at least one group selected from C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -aminoalkyl, C 5 -C 12 -aryl or C 5 -C 12 -aryl-C 1 -C 6 -alkyl groups,
  • the pyridine nucleus can be substituted with at least one group selected from C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -aminoalkyl, C 5 -C 12 -aryl or C 5 -C 12 -aryl-C 1 -C 6 -alkyl groups,
  • the pyrazole nucleus can be substituted with at least one group selected from C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -aminoalkyl, C 6 -C 12 -aryl or C 5 -C 12 -aryl-C 1 -C 6 -alkyl groups,
  • the triazole nucleus can be substituted with at least one group selected from C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -aminoalkyl, C 5 -C 12 -aryl or C 5 -C 12 -aryl-C 1 -C 6 -alkyl groups,
  • R 1 , R 2 , R 3 are selected independently of one another from the group consisting of
  • heteroaryl, heteroaryl-C 1 -C 6 -alkyl groups with 3 to 8 carbon atoms in the heteroaryl radical and at least one heteroatom selected from N, O and S which can be substituted with at least one group selected from C 1 -C 6 -alkyl groups and/or halogen atoms;
  • aryl-, aryl-C 1 -C 6 -alkyl groups with 5 to 12 carbon atoms in the aryl radical which if necessary can be substituted with at least one C 1 -C 6 -alkyl group and/or one halogen atom.
  • the invention relates to a composition
  • a composition comprising an enzyme and at least one of the ionic liquids defined above.
  • These compositions can be used as the starting point for carrying out the afore-mentioned enzymatically catalysed reactions.
  • the compositions according to the invention can also contain the educts (substrate) to be converted and as the reaction proceeds, naturally also the reaction products obtainable by the enzymatic reaction.
  • a still further aspect is thus the use of ionic liquids, especially the ionic liquids defined above, as the reaction medium or a constituent of the reaction medium in biocatalysis, i.e., carrying out enzymatically catalysed reactions on substrates.
  • alkyl, aryl, arylalkyl and alkylaryl sulphonate groups can be substituted by halogen atoms, especially fluorine, chlorine or bromine.
  • halogen atoms especially fluorine, chlorine or bromine.
  • perfluorinated alkyl and afore-mentioned aryl sulphonates such as trifluoromethane sulphonate (triflate).
  • triflate trifluoromethane sulphonate
  • alkyl, aryl, arylalkyl and alkylaryl carboxylate groups can be substituted by halogen atoms, especially fluorine, chlorine or bromine, Especially preferred are the fluorinated, in particular the perfluorinated alkyl and above-mentioned aryl carboxylates, such as trifluoromethane carboxylate (trifluoroacetate; CF 3 COO ⁇ ).
  • halogen atoms especially fluorine, chlorine or bromine
  • the fluorinated, in particular the perfluorinated alkyl and above-mentioned aryl carboxylates such as trifluoromethane carboxylate (trifluoroacetate; CF 3 COO ⁇ ).
  • CF 3 COO ⁇ trifluoromethane carboxylate
  • the C 1 -C 6 -alkyl groups mentioned in connection with the substituents can be replaced by C 2 -C 4 -alkyl groups independently of each other.
  • the C 1 -C 6 -alkoxy groups mentioned in connection with the substituents can be replaced by C 2 -C 4 -alkoxy groups independently of each other.
  • the C 5 -C 12 -aryl groups mentioned in connection with the substituents can be replaced by C 6 -C 10 -aryl groups independently of each other and the C 3 -C 8 -heteroaryl groups can be replaced by C 3 -C 6 -heteroaryl groups independently of one another.
  • the halogen atoms with which the alkyl, alkoxy and aryl groups can be substituted are selected from fluorine, chlorine, bromine and iodine, preferably fluorine, chlorine and bromine.
  • the radical R′ is a linear or branched aliphatic or alicyclic alkyl containing 1 to 8 carbon atoms or a C 6 -C 10 -aryl, C 6 -C 10 -aryl-C 1 -C 4 -alkyl or C 1 -C 4 -alkyl-C 6 -C 10 -aryl radical which can be substituted by halogen atoms.
  • the cations [A] are, for example, selected from trimethylphenyl ammonium, methyltrioctyl ammonium, tetrabutyl-phosphonium, 3-butyl-1-methyl-imidazolium, 3-ethyl-1-methyl-imidazolium, N-butyl pyridinium, N-ethyl pyridinium, diethyl pyrazolium, 1-ethyl-3-methylimidazolium, 1-butyl-3-methylimidazolium, 1-hexyl-3-methylimidazolium, 1-octyl-3-methylimidazolium, 1-decyl-3-methylimidazolium, 1-butyl-4-methylpyridinium, 1-butyl-3-methylpyridinium, 1-butyl-2-methylpyridinium, 1-butyl-pyridinium, butyl-methylimidazolium, nonyl-methyl-imidazolium, butyl
  • Ionic liquids and their production are known in the prior art.
  • the corresponding halide salt [cation] + X ⁇ is first formed and isolated by reacting an amine NR 1 N 2 R 3 , a phosphane PR 1 R 2 R 3 , an imidazole derivative having the general formula R 1 R 2+ N ⁇ CR 3 —R 5 —R 3 C ⁇ N + R 1 R 2 or a pyridinium derivative having the general formula R 1 R 2 N ⁇ CR 3 R 4+ with an alkyl chloride, alkyl bromide or alkyl iodide (F.
  • the halide salt is converted by the addition of a metal salt MY (with precipitation or separation of the salt MX or the product [A] + [Y] ⁇ from the respective solvent used)
  • [Y] ⁇ stands for a hexafluorophosphate, tetrafluoroborate, bis(trifluoromethyl sulphonyl)amide, perfluoroalkyl sulphonate and perfluoroalkyl carboxylate ion
  • M + stands for an alkali cation
  • the ionic liquid is used as the only reaction medium, i.e., free from further solvents.
  • the fraction of the ionic liquid in the reaction medium can however be between 0.1 and 99.9 percent by volume, preferably between 5 and 75 percent by volume, more preferably between 15 or 50 and 75 percent by volume relative to the total quantity of the reaction medium.
  • the reaction medium can also contain a further solvent.
  • a further solvent can be selected from the group consisting of water, buffer solutions (pH 2 to 10, preferably 5 to 8) and organic solvents.
  • Usable organic solvents are miscible with water or immiscible with water.
  • organic solvents mention may be made of methyl-tert-butyl ether, toluene, hexane, heptane, tert-butanol, glycols, polyalkylene glycols.
  • fundamentally all conventional solvents known in the field of enzyme catalysis can be considered.
  • ionic liquids offers significant advantages, such as, for example, an increase in the activity in the case of formate dehydrogenase, a significant increase in the yield in reactions with galactosidase, an increase in the enantioselectivity for lipases and an improvement in the educt solubility for hydrophobic educts.
  • the enzyme together with the total quantity of ionic liquid or a part thereof can be used repeatedly or in continuously operated reactors.
  • the enzymes can be selected from the class of oxidoreductases for regio- and stereoselective oxidation and reduction, from the class of glycosidases for the synthesis of oligosaccharides, from the class of lipases to obtain optically active products (among others, alcohols, amines, carboxylic acids) and from the class of lyases for synthesis, and hydrolases.
  • the method according to the invention can be carried out at temperatures between ⁇ 10° C. and 130° C., preferably in a temperature range between 10° C. and 80° C., especially preferably in a temperature range between 20° C. and 40° C.
  • the method can be carried out in a single-phase fashion or in a multiphase reaction system.
  • ionic liquids can be added to the reaction medium to increase the educt solubility.
  • formate dehydrogenase used for cofactor regeneration an increase in the reaction rate compared with the purely aqueous system is observed in the same concentration range of the ionic liquid (see Example 1). No deactivation of the enzyme was observed even when the time of influence of the ionic liquid was fairly long.
  • ionic liquids offer a valuable possibility for increasing the productivity of enzymatic reactions through an increase in the educt concentration. This is especially interesting for barely soluble to very barely soluble educts such as aromatic ketones or steroids.
  • glycosidases have not only been used for breaking bonds between saccharides but also for the synthesis of di- and oligosaccharides.
  • water-miscible solvents leads to reduced enzyme stability
  • yields no greater than 31% have been obtained even in the most recent studies (J. H. Yoon, J. S. Rhee, Carbohydr. Res. 2000, 327, 377; M. J. Hernaiz, D. H. G. Crout, J. Mol. Cat. B 2000, 10, 403).
  • the main problem in these reactions is the immediately initiated secondary hydrolysis of the product, catalysed by the same enzyme.
  • the galactosidase is very stable in the presence of ionic liquids and can be repeatedly used after separation by means of ultrafiltration without any change in the attainable yield and the product formation rate.
  • Ionic liquids also offer advantages in reverse hydrolysis for the synthesis of di- and oligosaccharides.
  • high educt concentrations together with additives, usually organic solvents, are used to reduce the water activity.
  • ionic liquids especially offer the advantage of a very good dissolving capacity for carbohydrates.
  • the enzyme has so far conventionally been separated by filtration and the reaction solution conventionally separated by distillation and the solvent fed back.
  • ionic liquids permits direct distillative separation of the reactands from the reaction mixture even in the presence of the enzyme so that a simplified procedure results. If the reactands possess suitable volatility, this procedure is not limited to lipases.
  • the conversion rate and the enantioselectivity are in some cases significantly improved, in individual cases a factor of 5 better.
  • the reaction in tert-butylmethyl ether which is also used as a solvent for lipase-catalysed reactions in industrial processes, is used for comparison.
  • NAD + to NADH+H + nicotinamide adenine dinucleotide
  • composition of the enzyme assay 1 ml buffer solution (50 mM triethanolamine hydrochloride, 1 mM dithiothreitol, hydrochloric acid) pH 7 is mixed with 0.1 ml of aqueous sodium formate solution (2.4 M) and 0.1 ml of enzyme solution (0.7 mg/ml, 8.4 U).
  • the enzyme solution already contains the cofactor NAD (6 mM).
  • composition of the reaction mixture 0.05 ml buffer solution (65 mM KH 2 PO 4 , 195 mM K 2 HPO 4 ) pH 7,3 is mixed with 0.5 ml N-acetyl glucosamine solution (GlcNAc 600 mM or 1.2 M in buffer solution), 0.25 ml lactose solution (250 mM in buffer solution) and 0.2 ml enzyme solution (10 mg/ml in buffer solution).
  • HPLC Conditions Column: Guard column Nucleosil C-18 5 ⁇ m; 10 mm, 4.6 mm ID; Preparatory column Chiracel OJ; 50 mm, 4.6 mm ID; Separating column Chiracel OJ; 250 mm, 4.6 mm ID Eluent: isocratic; 96.5% (v/v) n-hexane, 3.0% (v/v) isopropanol, 0.5% (v/v) ethanol Flux rate: 1 ml/mm Temperature: 38° C. Detection: UV detector (205 nm)
  • Example 3 Each 5 mg of lyophilised lipase (>30 U/mg) is mixed with 0.4 ml of a substrate solution as in Example 3. The further procedure corresponds to that described in Example 3.
  • TABLE 4 Enantioselective acylation of 1-phenyl ethanol, catalysed by lipase from Candida antarctica (Type A): conversion and enantiomer excess in ionic liquids compared to the standard reaction in tert-butylmethyl ether; Ionic liquid/solvent Conversion Enantiomer excess BMIm + PF 6 ⁇ + + NMIm + PF 6 ⁇ + + BMIm + BF 4 ⁇ ⁇ + HMIm + BF 4 ⁇ + + OMIm + BF 4 ⁇ + ⁇ BMIm + CF 3 SO 3 ⁇ + + +
  • Example 3 Each 5 mg of lyophilised lipase (>20 U/mg) is mixed with 0.4 ml of a substrate solution as in Example 3. The further procedure corresponds to that described in Example 3.
  • TABLE 6 Enantioselective acylation of 1-phenyl ethanol, catalysed by lipase from Alcaligines sp.: conversion and enantiomer excess in ionic liquids compared to the standard reaction in tert-butylmethyl ether, Ionic liquid/solvent Conversion Enantiomer excess BMIm + PF 6 ⁇ ⁇ + BMIm + BF 4 ⁇ ⁇ + HMIm + BF 4 ⁇ ⁇ + OMIm + BF 4 ⁇ ⁇ + 4-MBP + BF 4 ⁇ ⁇ + BMIm + CF 3 SO 3 ⁇ ⁇ +
  • lyophilised lipase 600 mg is mixed with 4 ml of ionic liquid (BMIm + (CF 3 SO 2 ) 2 N ⁇ ), 1.2 ml of vinyl acetate and 0.7 ml 1-phenyl ethanol and thoroughly mixed. The reaction mixture is incubated for 40 min at 40° C.
  • ionic liquid BMIm + (CF 3 SO 2 ) 2 N ⁇
  • the enzyme/ionic liquid mixture is cooled, re-mixed with 1.2 ml of vinyl acetate and 0.7 ml of 1-phenyl ethanol and again incubated for 40 min at 40° C.
  • reaction sequence involving incubation and distilling off can be repeated many times without the lipase activity diminishing.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)

Abstract

The invention relates to the implementation of enzyme-catalysed reactions in the presence of ionic liquids.

Description

  • The invention relates to compositions comprising an enzyme and ionic liquids as well as a method for carrying out enzyme-catalysed reactions in the presence of ionic liquids. [0001]
  • To date, enzymes have become firmly established as biocatalysts for reactions on the laboratory and industrial scale. Nevertheless, despite all the success with enzymatic reactions, there are still problems such as, for example, [0002]
  • low productivities as a result of too low educt solubilities; [0003]
  • low yields in equilibrium reactions; [0004]
  • insufficient selectivity in regio- and stereoselective conversions; [0005]
  • product inhibition; [0006]
  • the occurrence of side reactions (parallel, consecutive reactions). [0007]
  • There are known attempts to solve this problem by adding organic solvents (G. Carrea, S. Riva, Angew, Chem. 2000, 112, 2312; J. M. S. Cabral, M. R. Aires-Barros, H. Pinheiro, D. M. F. Prazeres, J. Biotechnol. 1997, 59, 133; M. N. Gupta, Eur. J. Riochem. 1992, 203, 25), by adding salts (A. M. Blinkorsky, Y. L. Khmelnitzky, J. S. Dordick, J. AM, Chem. Soc. 1999, 116, 2697) or by carrying out the reaction in microemulsions (B. Orlich, R. Schomähcker 1999, 65, 357-362). Frequently however, the improvements achieved thereby are not significant and do not justify the additional expenditure, or the enzyme stability decreases severely under these conditions (G. Carrea, S. Riva, Angew. Chem. 2000, 112, 2312). At low temperatures (<100° C.) ionic liquids are melting salts which represent a new class of solvents having a non-molecular ionic character. Although the first representatives have been known since 1914, ionic liquids have only been investigated intensively as solvents for chemical conversions in the last 15 years. Ionic liquids have no measurable vapour pressure. This is a major advantage from the process engineering point of view because in this way, the distillative separation of a reaction mixture is possible as an effective method for product separation. The known problems caused by azeotrope formation between solvents and products do not occur. Ionic liquids are temperature-stable up to above 200° C. By means of a suitable choice of cation and anion, it is possible to gradually adjust the polarity and thereby tune the solubility properties. The range goes from water-miscible ionic liquids through water-immiscible ionic liquids as far as those which themselves form two phases with organic solvents. The skilful utilization of the extraordinary solubility properties is the key to the successful use of ionic liquids as a new class of solvents. [0008]
  • Ionic liquids have already been successfully used as new types of media in two-phase catalysis or as the medium for liquid-liquid extraction). (P. Wasserscheid, W. Keim, Angew. Chem. 2000, 112, 3926). [0009]
  • According to the invention a substantial increase in the yield and selectivity was surprisingly established during the conversion of a wide range of educts with different enzymes in the presence of ionic liquids, which represents a significant improvement compared with the prior art. No adverse effects of the ionic liquid on the enzyme stability were established and in individual cases, even a stabilising effect was found. [0010]
  • This is unexpected and surprising bearing in mind th ionic nature of the ionic liquids and the strong interactions thereby possible between the ionic liquids and the enzyme with its likewise charged groups. [0011]
  • It was also found that ionic liquids can be used as co-solvents to improve the solubility of educts and products. [0012]
  • The invention relates to a method for the conversion of substances (educts) in the presence of enzymes as a catalyst in a reaction medium comprising ionic liquids. [0013]
  • The ionic liquid can be miscible with water or immiscible with water. In the same way, it is possible to carry out a single-phase, two-phase or multi-phase reaction. [0014]
  • The ionic liquids comprise compounds having the general formula [0015]
  • [A]n +[Y]n−,
  • where [0016]
  • n 1 or 2 and [0017]
  • the anion [Y][0018] n− is selected from the group comprising tetrafluoroborate ([BF4]), tetrachloroborate ([BCl4]), hexafluorophosphate ([PF6]), hexafluoroantimonate ([SbF6]), hexafluoroarsenate ([AsF6]), tetrachloroaluminate ([AlCl4]), trichlorozincate [(ZnCl3]), dichlorocuprate, sulphate ([SO4]2−), carbonate ([CO3]2−), fluorosulphonate, [R′—COO], [R′—SO3] or [(R′—SO2)2N], and R′ is a linear or branched aliphatic or alicyclic alkyl containing 1 to 12 carbon atoms or a C5-C18-aryl, C5-C18-aryl-C1-C6-alkyl or C1-C6-alkyl-C5-C18-aryl radical that can be substituted by halogen atoms, the cation [A]+ is selected from
  • quaternary ammonium cations having the general formula [0019]
  • [NR1R2R3R]+,
  • phosphonium cations having the general formula [0020]
  • [PR1R2R3R]+,
  • imidazolium cations having the general formula [0021]
    Figure US20040096932A1-20040520-C00001
  • where the imidizole nucleus can be substituted with at least one group selected from C[0022]   1-C6-alkyl, C1-C6-alkoxy, C1-C6-aminoalkyl, C5-C12-aryl or C5-C12-aryl-C1-C6-alkyl groups,
  • pyridinium cations having the general formula [0023]
    Figure US20040096932A1-20040520-C00002
  • where the pyridine nucleus can be substituted with at least one group selected from C[0024]   1-C6-alkyl, C1-C6-alkoxy, C1-C6-aminoalkyl, C5-C12-aryl or C5-C12-aryl-C1-C6-alkyl groups,
  • pyrazolium cations having the general formula [0025]
    Figure US20040096932A1-20040520-C00003
  • where the pyrazole nucleus can be substituted with at least one group selected from C[0026]   1-C6-alkyl, C1-C6-alkoxy, C1-C6-aminoalkyl, C6-C12-aryl or C5-C12-aryl-C1-C6-alkyl groups,
  • and triazolium cations having the general formula [0027]
    Figure US20040096932A1-20040520-C00004
  • where the triazole nucleus can be substituted with at least one group selected from C[0028]   1-C6-alkyl, C1-C6-alkoxy, C1-C6-aminoalkyl, C5-C12-aryl or C5-C12-aryl-C1-C6-alkyl groups,
  • and the radicals R[0029]   1, R2, R3 are selected independently of one another from the group consisting of
  • hydrogen; [0030]
  • linear or branched, saturated or unsaturated, aliphatic or alicyclic alkyl groups with 1 to 20 carbon atoms; [0031]
  • heteroaryl, heteroaryl-C[0032] 1-C6-alkyl groups with 3 to 8 carbon atoms in the heteroaryl radical and at least one heteroatom selected from N, O and S which can be substituted with at least one group selected from C1-C6-alkyl groups and/or halogen atoms;
  • aryl-, aryl-C[0033] 1-C6-alkyl groups with 5 to 12 carbon atoms in the aryl radical which if necessary can be substituted with at least one C1-C6-alkyl group and/or one halogen atom.
  • In a further aspect the invention relates to a composition comprising an enzyme and at least one of the ionic liquids defined above. These compositions can be used as the starting point for carrying out the afore-mentioned enzymatically catalysed reactions. Accordingly, in addition to the enzyme (biocatalyst), the compositions according to the invention can also contain the educts (substrate) to be converted and as the reaction proceeds, naturally also the reaction products obtainable by the enzymatic reaction. [0034]
  • A still further aspect is thus the use of ionic liquids, especially the ionic liquids defined above, as the reaction medium or a constituent of the reaction medium in biocatalysis, i.e., carrying out enzymatically catalysed reactions on substrates. [0035]
  • In a particular development of the invention the alkyl, aryl, arylalkyl and alkylaryl sulphonate groups (anion [Y]) can be substituted by halogen atoms, especially fluorine, chlorine or bromine. Especially preferred are the perfluorinated alkyl and afore-mentioned aryl sulphonates such as trifluoromethane sulphonate (triflate). As non-halogenated representatives mention may be made of methane sulphonate, benzene sulphonate and the toluene sulphonate group as well as other sulphonate leaving groups known in the prior art. [0036]
  • In a further development of the invention the alkyl, aryl, arylalkyl and alkylaryl carboxylate groups can be substituted by halogen atoms, especially fluorine, chlorine or bromine, Especially preferred are the fluorinated, in particular the perfluorinated alkyl and above-mentioned aryl carboxylates, such as trifluoromethane carboxylate (trifluoroacetate; CF[0037] 3COO). As non-halogenated representatives mention may be made of the acetate and benzoate group as well as all other carboxylate leaving groups known in the prior art.
  • In preferred developments of the invention the C[0038] 1-C6-alkyl groups mentioned in connection with the substituents can be replaced by C2-C4-alkyl groups independently of each other. Likewise, the C1-C6-alkoxy groups mentioned in connection with the substituents can be replaced by C2-C4-alkoxy groups independently of each other. In a further alternative of the invention the C5-C12-aryl groups mentioned in connection with the substituents can be replaced by C6-C10-aryl groups independently of each other and the C3-C8-heteroaryl groups can be replaced by C3-C6-heteroaryl groups independently of one another. The halogen atoms with which the alkyl, alkoxy and aryl groups can be substituted are selected from fluorine, chlorine, bromine and iodine, preferably fluorine, chlorine and bromine.
  • In a preferred development the radical R′ is a linear or branched aliphatic or alicyclic alkyl containing 1 to 8 carbon atoms or a C[0039] 6-C10-aryl, C6-C10-aryl-C1-C4-alkyl or C1-C4-alkyl-C6-C10-aryl radical which can be substituted by halogen atoms.
  • The cations [A] are, for example, selected from trimethylphenyl ammonium, methyltrioctyl ammonium, tetrabutyl-phosphonium, 3-butyl-1-methyl-imidazolium, 3-ethyl-1-methyl-imidazolium, N-butyl pyridinium, N-ethyl pyridinium, diethyl pyrazolium, 1-ethyl-3-methylimidazolium, 1-butyl-3-methylimidazolium, 1-hexyl-3-methylimidazolium, 1-octyl-3-methylimidazolium, 1-decyl-3-methylimidazolium, 1-butyl-4-methylpyridinium, 1-butyl-3-methylpyridinium, 1-butyl-2-methylpyridinium, 1-butyl-pyridinium, butyl-methylimidazolium, nonyl-methyl-imidazolium, butyl-methylimidazolium, hexyl-methyl-imidazolium, octyl-methylimidazolium, 4-methyl-butyl-pyridinium, triethyl ammonium, triethylmethyl ammonium, butylmethylpyridinium, propyl ammonium, methyl-methyl-imldazolium, ethyl-methyl-imidazolium, butyl-methyl-imidazolium. [0040]
  • Ionic liquids and their production are known in the prior art. For the synthesis of ionic liquids using hexafluorophosphate, tetrafluoroborate, bis(trifluoromethylsulphonyl)amide, perfluoroalkyl sulphonate and perfluoroalkyl carboxylate ions, the corresponding halide salt [cation][0041] +X is first formed and isolated by reacting an amine NR1N2R3, a phosphane PR1R2R3, an imidazole derivative having the general formula R1R2+N═CR3—R5—R3C═N+R1R2 or a pyridinium derivative having the general formula R1R2N═CR3R4+ with an alkyl chloride, alkyl bromide or alkyl iodide (F. H. Hurley, T. P. Wier, Jr., J. Electrochem. Soc. 1951, 98, 207-212; J. S. Wilkes, J. A. Levisky, R. A. Wilson, C. L. Hussey, Inorg. Chem. 1982, 21, 1263-1264; A. A. K. Abdul-Sada, P. W. Ambler, P. K. G. Hodgson, K. R. Seddon, N. J. Steward, WO-A-95/21871) R. H. Dubois, M. J. Zaworotko, P. S. White, Inorg. Chem. 1989, 28, 2019-2020; J. F. Knifton, J. Mol. Catal. 1987, 43, 65-78; C. P. M. Lacroix, F. H, M. Dekker, A. G. Talma, J. W. F. Seetz, EP-A-0989134). Starting from the [A]+X halide salt which has been formed and isolated, two different paths are known for the synthesis of ionic liquids using hexafluorophosphate, tetrafluoroborate, bis(trifluoromethyl sulphonyl)-amide, perfluoroalkyl sulphonate and perfluoroalkyl carboxylate ions. On the one hand, the halide salt is converted by the addition of a metal salt MY (with precipitation or separation of the salt MX or the product [A]+[Y] from the respective solvent used) where [Y] stands for a hexafluorophosphate, tetrafluoroborate, bis(trifluoromethyl sulphonyl)amide, perfluoroalkyl sulphonate and perfluoroalkyl carboxylate ion and M+ stands for an alkali cation (J. S. Wilkes, M. J. Zaworotko, J. Chem. Soc. Chem. Commun. 1992, 965-967; Y. Chauvin, L. Muβmann, H. Olivier, Angew. Chem. 1995, 107, 2941-2943; P. A. Z. Suarez, J. E. L. Dullius, S. Einloft, R. F. de Souza, J. Dupont, Polyhedron, 1996, 15, 1217-1219; P. Bonhôte, A.-P. Dias, N. Papageorgiou, K. Kalyanasundaram, M. Grätzel, Inorg. Chem. 1996, 35, 1168-1178; C. M. Gordon, J. D. Holbrey, A. R. Kennedy, K. R. Seddon, J. Mater. Chem. 1998, 8, 2627-2638; P. A. Z. Suarez, S. Einloft, J. E. L. Dullius, R. F. de Souza, J. Dupont, J. Chim. Phys. 1998, 95, 1626-1639; A. J. Carmichael, C. Hardacre, J. D. Holbrey, M. Nieuwenhuyzen, K. R. Seddon, Anal. Chem. 1999, 71, 4572-4574; J. D. Holbrey, K. R. Seddon, J. Chem. Soc., Dalton Trans. 1999, 2133-2140). On the other hand, by the addition of a strong acid H+[Y] the halide ion is displaced with the release of H+X and exchanged for [Y], where [Y] here stands for a hexafluorophosphate, tetrafluoroborate, bis(trifluoromethylaulphonyl) amide, perfluoroalkyl sulphonate and perfluoroalkyl carboxylate ion (J. Fuller, R. T. Carlin, H. C. de Long, D. Haworth, J. Chem. Soc. Chem. Commun. 1994, 299-300). However, ionic liquids can especially advantageously be produced halide-free using the method described in EP 00118441.5.
  • In a development of the method according to the invention the ionic liquid is used as the only reaction medium, i.e., free from further solvents. The fraction of the ionic liquid in the reaction medium can however be between 0.1 and 99.9 percent by volume, preferably between 5 and 75 percent by volume, more preferably between 15 or 50 and 75 percent by volume relative to the total quantity of the reaction medium. [0042]
  • In addition to the ionic liquid, the reaction medium can also contain a further solvent. This can be selected from the group consisting of water, buffer solutions (pH 2 to 10, preferably 5 to 8) and organic solvents. Usable organic solvents are miscible with water or immiscible with water. AB examples of organic solvents mention may be made of methyl-tert-butyl ether, toluene, hexane, heptane, tert-butanol, glycols, polyalkylene glycols. In addition, however, fundamentally all conventional solvents known in the field of enzyme catalysis can be considered. [0043]
  • All enzymes in EC classes 1 to 6 can fundamentally be considered. The enzyme classification is recommended by the “Nomenclature Committee of the International Union of Biochemistry and Molecular Biology” (IUBMB). The enzyme is either homogeneously dissolved but can also be used as a suspension or as an immobilisate on an inert carrier. [0044]
  • It was found according to the invention that the presence of ionic liquids in the reaction medium during enzymatically catalysed reactions results in an improvement in the substrate solubility (biocompatibility), an improvement in the enzyme activity, an improvement in the selectivity, a reduction in product inhibition, suppression of aide reactions (parallel, consecutive reactions) and/or an increase in enzyme stability. The examples prove that enzymes from different classes can be used, wherein the use of ionic liquids offers significant advantages, such as, for example, an increase in the activity in the case of formate dehydrogenase, a significant increase in the yield in reactions with galactosidase, an increase in the enantioselectivity for lipases and an improvement in the educt solubility for hydrophobic educts. [0045]
  • According to the invention, the enzyme together with the total quantity of ionic liquid or a part thereof can be used repeatedly or in continuously operated reactors. [0046]
  • The enzymes can be selected from the class of oxidoreductases for regio- and stereoselective oxidation and reduction, from the class of glycosidases for the synthesis of oligosaccharides, from the class of lipases to obtain optically active products (among others, alcohols, amines, carboxylic acids) and from the class of lyases for synthesis, and hydrolases. [0047]
  • The method according to the invention can be carried out at temperatures between −10° C. and 130° C., preferably in a temperature range between 10° C. and 80° C., especially preferably in a temperature range between 20° C. and 40° C. [0048]
  • The method can be carried out in a single-phase fashion or in a multiphase reaction system. [0049]
  • Some effects arising from the use of ionic liquids as a reaction medium or as a constituent of reaction media for enzymatic reactions will be described below as examples. For example, alcohol dehydrogenases from various sources are used among others for the enzymatic reduction of ketones. The solubility of hydrophobic ketones can be improved by the addition of organic solvents; however, this generally results in a reduction in the enzyme activity and stability (W. Hummel, Biochem. Eng. Biotechnol. 1997, 58, 145; A. Liese, T. Zelinski, M. -R. Kula, H. Kierkels, M. Karutz, U. Kragl, C. Wandrey, J. Mol. Cat. B 1998, 4, 91). In a similar fashion, water-miscible ionic liquids can be added to the reaction medium to increase the educt solubility. For the formate dehydrogenase used for cofactor regeneration, an increase in the reaction rate compared with the purely aqueous system is observed in the same concentration range of the ionic liquid (see Example 1). No deactivation of the enzyme was observed even when the time of influence of the ionic liquid was fairly long. Thus, ionic liquids offer a valuable possibility for increasing the productivity of enzymatic reactions through an increase in the educt concentration. This is especially interesting for barely soluble to very barely soluble educts such as aromatic ketones or steroids. [0050]
  • For about 20 years glycosidases have not only been used for breaking bonds between saccharides but also for the synthesis of di- and oligosaccharides. Despite many attempts to use water-miscible solvents (leads to reduced enzyme stability), by means of the generally expensive activation of educts, yields no greater than 31% have been obtained even in the most recent studies (J. H. Yoon, J. S. Rhee, Carbohydr. Res. 2000, 327, 377; M. J. Hernaiz, D. H. G. Crout, J. Mol. Cat. B 2000, 10, 403). The main problem in these reactions is the immediately initiated secondary hydrolysis of the product, catalysed by the same enzyme. Surprisingly, this secondary hydrolysis is almost completely suppressed in the presence of ionic liquids with otherwise the same enzyme activity. For the example of β-galactosidase-catalysed synthesis of N-acetyl lactosamine, an important building block for pharmacologically relevant oligosaccharide, it was shown that the presence of ionic liquids increases the yield above 55% when using lactose as an inexpensive donor. A maximum of 30% is achieved without the addition of ionic liquids; however, the product concentration drops rapidly to values of <10% as a result of the secondary hydrolysis. Since the secondary hydrolysis does not take place in the presence of ionic liquids, a simplified reaction process is obtained since it is not necessary to follow the reaction and interrupt it at the maximum product yield. The galactosidase is very stable in the presence of ionic liquids and can be repeatedly used after separation by means of ultrafiltration without any change in the attainable yield and the product formation rate. [0051]
  • Ionic liquids also offer advantages in reverse hydrolysis for the synthesis of di- and oligosaccharides. In this case, high educt concentrations together with additives, usually organic solvents, are used to reduce the water activity. Here ionic liquids especially offer the advantage of a very good dissolving capacity for carbohydrates. In the enzymatic synthesis of lactose, it was possible to increase the yield by a factor of 2 and reduce the reaction time by a factor of 5 compared with the literature (K. Ajisaka, H. Fujimoto, H. Nishida, Carbohydr. Res. 180, 35-42 (1988)). [0052]
  • The use of lipases in the presence of organic solvents in single- or two-phase reactions is prior art (G. Carrea, S. Riva, Angew. Chem. 2000, 112, 2312, U. T. Bornscheuer, R. J. Kazlauskas, Hydrolases in Organic Synthesis—Regio- and stereoselective Biotransformations, Wiley-VCH, Weinheim, 1999, A. Liese, K. Seelbach, C. Wandrey, Industrial Biotransformations, Wiley-VCH, Weinheim, 2000; M. C. Parker, S. A. Brown, L. Robertson, N. J. Turner, Chem. Commun. 1998, 2247). However, the enzyme has so far conventionally been separated by filtration and the reaction solution conventionally separated by distillation and the solvent fed back. The use of ionic liquids permits direct distillative separation of the reactands from the reaction mixture even in the presence of the enzyme so that a simplified procedure results. If the reactands possess suitable volatility, this procedure is not limited to lipases. In an investigation of various lipases for racemate splitting in the presence of ionic liquids it was surprisingly established in several cases that the conversion rate and the enantioselectivity are in some cases significantly improved, in individual cases a factor of 5 better. The reaction in tert-butylmethyl ether which is also used as a solvent for lipase-catalysed reactions in industrial processes, is used for comparison. [0053]
  • The results show that ionic liquids as a reaction medium for enzymatic conversions have numerous advantages compared with the conditions established as the prior art and can be used as biocompatible solvents to specifically influence conversions. [0054]
  • The invention is described in detail by the following examples without however being restricted to these.[0055]
  • EXAMPLES
  • The following abbreviations were used for the description of components used in the examples: [0056]
    tert-butylmethylether tBME, MTBE
    Butyl-methyl-imidazolium PF6 BMIm+ PF6
    Nonyl-methyl-imidazolium PF6 NMIm+ PF6
    Butyl-methyl-imidazolium BF4 BMIm+ BF4
    Hexyl-methyl-imidazolium BF4 HMIm+ BF4
    Octyl-methyl-imidazolium BF4 OMIm+ BF4
    4-methyl-butyl-pyridinium BF4 4-MBPy+ BF4
    Triethylammonium-methyl sulphate Et3NH+ MeSO4
    Triethylmethylammonium-methyl Et3NMe+ MeSO4
    sulphate
    Butylmethyl-pyridinium BF4 BMPy+ BF4
    Propylammonium-nitrate PrNH3 + NO3
    Methyl-methyl-imidazolium-methyl MeSO4
    sulphate MMIm+
    Ethyl-methyl-imidazolium-benzoate EMIm+ PhCO2
    Butyl-methyl-imidazolium-trifluoro BMIm+ CF3SO3
    methane sulphonate
    (=triflate)
    Butyl-methyl-imidazolium-bis- BMIm+ (CF3SO2)2N
    trifluoromethyl sulphonyl)-imidate
  • 1. Formate Dehydrogenase from [0057] Candida boidinii (FDH)
  • The FDH-catalysed oxidation of formic acid to carbon dioxide by the reduction of nicotinamide adenine dinucleotide (NAD[0058] + to NADH+H+) is used as the test reaction to determine the enzyme activity. In the enzyme assay the increase in NADH with time at 25° C. is detected photometrically at a wavelength of 340 nm.
  • Composition of the enzyme assay: 1 ml buffer solution (50 mM triethanolamine hydrochloride, 1 mM dithiothreitol, hydrochloric acid) pH 7 is mixed with 0.1 ml of aqueous sodium formate solution (2.4 M) and 0.1 ml of enzyme solution (0.7 mg/ml, 8.4 U). The enzyme solution already contains the cofactor NAD (6 mM). [0059]
  • In order to test the influence of water-soluble ionic liquids on the enzyme activity, the volume of the buffer solution in the assay is gradually reduced by 25 vol % and replaced by the ionic liquid. [0060]
    TABLE 1
    NAD reduction by formate dehydrogenase from
    Candida boidinii; enzyme activity compared
    with the standard reaction in the buffer solution
    Ionic liquid 25 vol % 50 vol % 75 vol%
    MMIm+ MeSO4 ± + +
  • 2. β-galactosidase from [0061] Bacillus circulans for Synthesis of N-acetyl Lactosamine
  • The influence of ionic liquids on the progress of β-Gal-catalysed tranagalactosylation starting from lactose and N-acetyl glucosamine is studied. For this purpose concentration-time profiles of this synthesis in the presence and absence of ionic liquids are recorded and compared. [0062]
  • In each series of tests 10 reactions were started in parallel in 1 ml GC glasses. At 10 minute intervals the reactions are stopped by boiling at 100° C., the reaction solution is filtered (Minisart RC 4 Sartorius injection filter) and the concentration of the reaction components at this time is determined chromatographically (Aminex HPX-87H cation exchange column from BioRad with a corresponding pre-column, 0.006 M sulphuric acid as eluent with a flux of 0.8 ml/min and a column temperature of 65° C. Detection is accomplished using UV at 208 nm and using the refractive index). [0063]
  • Composition of the reaction mixture: 0.05 ml buffer solution (65 mM KH[0064] 2PO4, 195 mM K2HPO4) pH 7,3 is mixed with 0.5 ml N-acetyl glucosamine solution (GlcNAc 600 mM or 1.2 M in buffer solution), 0.25 ml lactose solution (250 mM in buffer solution) and 0.2 ml enzyme solution (10 mg/ml in buffer solution).
  • By exchanging buffer solution for ionic liquid in the substrate solutions, the fraction of ionic liquid in the reaction medium is gradually increased. The following substrate solutions are thus obtained: [0065]
  • a) 0.50 ml N-acetyl glucosamine solution (600 mM in 1:4 MMIm[0066] + MeSO4 : buffer solution)
  • b) 0.50 ml N-acetyl glucosamine solution (600 mM in 1:4 MMIm[0067] + MeSO4 : buffer solution) 0.25 ml lactose solution (250 mM in 1:4 MMIm+ MeSO4 : buffer solution)
  • c) 0.50 ml N-acetyl glucosamine solution (1.2 M in 1:2 MMIm[0068] + MeSO4 : buffer solution) 0.25 ml lactose solution (250 mM in 1:2 MMIm+ MeSO4 : buffer solution)
  • d) 0.50 ml N-acetyl glucosamine solution (600 mM in 1;4 BMIm[0069] + H2PO4 /Cl: buffer solution)
    TABLE 2
    Synthesis of N-acetyl lactosamine by β-
    galactosidase from Bacillus circulans with and
    without ionic liquid
    Lactose/ Yield Yield
    Reaction Fraction GlcNAc [%] [%] after
    medium [vol %] ratio after 60 min 100 min
    Phosphate 1:2.4  5  3
    buffer
    MMIm+ MeSO4 a) 12.5 1:2.4 40 40
    b) 18.75 1:2.4 44 43
    c) 25 1:4.8 49 55
    (90 min)
    BMIm+ H2PO4 / d) 12.5 1:2.4 39 30
    Cl
  • 3. Enantioselective Acylation of R,S-1-Phenylethanol by Catalysis with Lipase from [0070] Candida antarctica (Type B) in Ionic Liquids
  • 4.4 ml of an ionic liquid in accordance with Table 3 or tert-butylmethyl ether are mixed with 122 μl of vinyl acetate and 54 μl of 1-phenyl ethanol so that a substrate solution with approximately 0.1 mol/l of 1-phenyl ethanol and 0.3 mol/l of vinyl acetate is obtained. Each 1 mg of lyophilised lipase (>120 U/mg) is mixed with 0.4 ml of substrate solution, thoroughly mixed and incubated at 24° C. for 3-4 days, shaking slightly. [0071]
  • For further processing 100 μl of the reaction formulation is mixed with 1 ml of n-hexane/isopropanol (97.5/2.5 v/v) and mixed thoroughly. This hexane/isopropanol extract is used to determine the concentrations and enantiomer ratios of 1-phenyl ethanol and 1-phenylethyl acetate using HPLC. The conversion and the enantiomer excess were calculated from these concentrations (see Table 3). [0072]
  • HPLC Conditions: [0073]
    Column: Guard column Nucleosil C-18 5 μm; 10 mm,
    4.6 mm ID;
    Preparatory column Chiracel OJ; 50 mm,
    4.6 mm ID;
    Separating column Chiracel OJ; 250 mm,
    4.6 mm ID
    Eluent: isocratic;
    96.5% (v/v) n-hexane,
     3.0% (v/v) isopropanol,
     0.5% (v/v) ethanol
    Flux rate: 1 ml/mm
    Temperature: 38° C.
    Detection: UV detector (205 nm)
  • [0074]
    TABLE 3
    Enantioselective acylation of 1-phenyl ethanol, catalysed by
    lipase from Candida antarctica (Type B): conversion and enantiomer
    excess in ionic liquids compared to the standard reaction in
    tert-butylmethyl ether; (+) good to better, (±) the same,
    (−) poor to none.
    Ionic liquid/solvent Conversion Enantiomer excess
    NMIm+ PF6 ± +
    BMIm+ BF4 + +
    HMIm+ BF4 ± +
    OMIm+ BF4 + +
    4-MBP+ BF4 + +
    BMIm+ CF3SO3 + +
    BMIm+ (CF3SO2)2N + +
  • 4. Enantioselective Acylation of R,S-1-Phenyl Ethanol by Catalysis with Lipase from [0075] Candida antarctica (Type A) in Ionic Liquids
  • Each 5 mg of lyophilised lipase (>30 U/mg) is mixed with 0.4 ml of a substrate solution as in Example 3. The further procedure corresponds to that described in Example 3. [0076]
    TABLE 4
    Enantioselective acylation of 1-phenyl
    ethanol, catalysed by lipase from Candida
    antarctica (Type A): conversion and
    enantiomer excess in ionic liquids compared
    to the standard reaction in tert-butylmethyl ether;
    Ionic liquid/solvent Conversion Enantiomer excess
    BMIm+ PF6 + +
    NMIm+ PF6 + +
    BMIm+ BF4 ± +
    HMIm+ BF4 + +
    OMIm+ BF4 + ±
    BMIm+ CF3SO3 + +
  • 5. Enantioselective Acylation of R,S-1-Phenyl Ethanol by Catalysis of Lipase from Pseudomonas _sp. in Ionic Liquids [0077]
  • Each 3 mg of lyophilised lipase (400 U/mg) is mixed with 0.4 ml of a substrate solution as in Example 3. The further procedure corresponds to that described in Example 3. [0078]
    TABLE 5
    Enantioselective acylation of 1-phenyl
    ethanol, catalysed by lipase from Pseudomonas
    sp.: conversion and enantiomer excess in
    ionic 1iquids compared to the standard
    reaction in tert-butylmethyl ether;
    Ionic liquid/solvent Conversion Enantiomer excess
    MIm+ PF6 ± +
    4-MBP+ BF4 ± +
    BMIm+ CF3SO3 + +
    BMIm+ (CF3SO2)2N + +
  • 6. Enantioselective Acylation of R,S-1-Phenyl Ethanol by Catalysis of Lipase from Alcaligines sp. in Ionic Solvents [0079]
  • Each 5 mg of lyophilised lipase (>20 U/mg) is mixed with 0.4 ml of a substrate solution as in Example 3. The further procedure corresponds to that described in Example 3. [0080]
    TABLE 6
    Enantioselective acylation of 1-phenyl
    ethanol, catalysed by lipase from Alcaligines
    sp.: conversion and enantiomer excess in
    ionic liquids compared to the standard
    reaction in tert-butylmethyl ether,
    Ionic liquid/solvent Conversion Enantiomer excess
    BMIm+ PF6 ± +
    BMIm+ BF4 ± +
    HMIm+ BF4 ± +
    OMIm+ BF4 ± +
    4-MBP+ BF4 ± +
    BMIm+ CF3SO3 ± +
  • 7. Recycling of the Lipase from [0081] Candida antarctica (Type B) in Ionic Liquids by Distillation
  • 600 mg of lyophilised lipase (approx. 10 U/mg) is mixed with 4 ml of ionic liquid (BMIm[0082] + (CF3SO2)2N), 1.2 ml of vinyl acetate and 0.7 ml 1-phenyl ethanol and thoroughly mixed. The reaction mixture is incubated for 40 min at 40° C.
  • The non-converted educts and the reaction product 1-phenyl acetate is then distilled off (85° C., 0.06 mbar). [0083]
  • The enzyme/ionic liquid mixture is cooled, re-mixed with 1.2 ml of vinyl acetate and 0.7 ml of 1-phenyl ethanol and again incubated for 40 min at 40° C. [0084]
  • The reaction sequence involving incubation and distilling off can be repeated many times without the lipase activity diminishing. [0085]
  • 8. Synthesis of Lactose by Reverse Hydrolysis with β-galactosidase from [0086] Bacillus circulans
  • 100 mmol/l of glucose, 20 mmol/l of galactose and 2 mg/ml of galactosidase are incubated at 35° C. in a mixture of water and MMIm MeSO[0087] 4 for 24 h. The reaction is stopped by boiling for 10 minutes at 100° C., the reaction solution is filtered (Minisart RC 4 Sartorius injection filter) and the concentration of the reaction components at this time is determined chromatogaphically (Aminex HPX-87H cation exchange column from BioRad with corresponding preparatory column, 0.006 M sulphuric acid as eluent with a flux of 0.8 ml/min and a column temperature of 65° C. Detection is accomplished using UV at 208 nm and using the refractive index).
  • The fraction of ionic liquid is increased from 0 to 100 per cent by volume. As a result of water traces in the ionic liquid and the educts, a water content of 0.6% is obtained for 100% ionic liquid. After 24 hours, the conversion no longer increases. The following lactose yields are obtained depending on the quantity of ionic liquid: [0088]
    Praction of ionic liquid in % Yield [%]
    0 0
    10 0
    20 0
    30 4
    40 12
    50 15
    60 15
    70 16
    80 16
    90 16
    100 17

Claims (13)

1. A method for the conversion of substances in the presence of enzymes as a catalyst in a reaction medium comprising at least one ionic liquid, wherein the enzyme is selected from the group of oxidoreductases, lipases, galactosidases, glycosidases, lyases and enzymes in EC class 6.
2. The method according to claim 1, characterized in that the ionic liquid has the general formula
[Aln +[Y]n−,
where
n=1 or 2 and
the anion [Y]n− 0 is selected from the group comprising tetrafluoroborate ([BF4]), tetrachloroborate ([BCl4]), hexafluorophosphate ([PF6]), hexafluoroantimonate ([SbF6]), hexafluoroarsenate ([AsF6]), tetrachloroaluminate ([AlCl4]), trichlorozincate (ZnCl3]), dichlorocuprate, sulphate ([SO4]2−), carbonate ([CO3]2−), fluorosulphonate, [R′—COO], [R′—SO3] or [(R′—SO2)2N], and R′ is a linear or branched aliphatic or alicyclic alkyl containing 1 to 12 carbon atoms or a C5-C18-aryl, C5-C18-aryl-C1-C6-alkyl or C1-C6-alkyl-C5-C18-aryl radical that can be substituted by halogen atoms,
the cation [A]+ is selected from
quaternary ammonium cations having the general formula
[NR1R2R3R]+,
phosphonium cations having the general formula
[PR1R2R3R]+,
imidazolium cations having the general formula
Figure US20040096932A1-20040520-C00005
 where the imidizole nucleus can be substituted with at least one group selected from C1-C6-alkyl, C1-C6-alkoxy, C1-C6-aminoalkyl, C5-C12-aryl or C5-C12-aryl-C1-C6-alkyl groups,
pyridinium cations having the general formula
Figure US20040096932A1-20040520-C00006
 where the pyridine nucleus can be substituted with at least one group selected from C1-C6-alkyl, C1-C6-alkoxy, C1-C6-aminoalkyl, C5-C12-aryl or C5-C12-aryl-C1-C6-alkyl groups,
pyrazolium cations having the general formula
Figure US20040096932A1-20040520-C00007
 where the pyrazole nucleus can be substituted with at least one group selected from C1-C6-alkyl, C1-C6-alkoxy, C1-C6-aminoalkyl, C5-C12-aryl or C5-C12-aryl-C1-C6-alkyl groups,
and triazolium cations having the general formula
Figure US20040096932A1-20040520-C00008
 where the triazole nucleus can be substituted with at least one group selected from C1-C6-alkyl, C1-C6-alkoxy, C1-C6-aminoalkyl, C5-C12-aryl or C5-C12-aryl-C1-C6-alkyl groups,
 and the radicals R1, R2, R3 are selected independently of one another from the group consisting of
hydrogen;
linear or branched, saturated or unsaturated, aliphatic or alicyclic alkyl groups with 1 to 20 carbon atoms;
heteroaryl, heteroaryl-C1-C6-alkyl groups with 3 to 8 carbon atoms in the heteroaryl radical and at least one heteroatom selected from N, O and S which can be substituted with at least one group selected from C1-C6-alkyl groups and/or halogen atoms;
aryl-, aryl-C1-C6-alkyl groups with 5 to 12 carbon atoms in the aryl radical which if necessary can be substituted with at least one C1-C6-alkyl group and/or one halogen atom.
3. The method according to any one of the preceding claims, characterised in that the fraction of the ionic liquid in the reaction medium is 0.1 to 99.9 percent by volume.
4. The method according to any one of the preceding claims, characterised in that in addition to the ionic liquid, the reaction medium also contains a further solvent.
5. The method according to any one of the preceding claims, characterized in that the further solvent is water or an organic solvent.
6. The method according to any one of the preceding claims, characterised in that the reaction is carried out at temperatures of −10° C. to 130° C.
7. The method according to any one of the preceding claims, characterised in that the reaction is carried out in a single-phase fashion or in a multiphase reaction system.
8. A composition comprising an enzyme selected from the groups of oxidoreductases, lipases, galactosidases, glycosidases, lyases and enzymes in EC class 6 and at least one ionic liquid.
9. The composition according to claim a, characterised in that the ionic liquid is defined as in claim 2.
10. The composition according to claim 8 or claim 9, characterised in that it additionally contains a substrate.
11. The composition according to any one of claims 8 to 10, characterised in that it contains the ionic liquid as a reaction medium or as a constituent of the reaction medium.
12. Use of ionic liquids as a reaction medium or as a constituent of the reaction medium for enzymatically catalysed reactions, wherein the enzyme is selected from the group of oxidoreductaaes, lipases, galactosidases, glycosidases, lyases and enzymes in EC class 6.
13. The use according to claim 12 as a reaction medium or as a constituent of the reaction medium in reverse hydrolysis for the synthesis of di- and oligosaccharides.
US10/416,067 2000-11-08 2001-11-07 Enzyme catalysis in the presence of ionic liquids Abandoned US20040096932A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US11/440,321 US20060211096A1 (en) 2000-11-08 2006-05-23 Enzyme catalysis in the presence of ionic liquids
US12/119,214 US7754462B2 (en) 2000-11-08 2008-05-12 Enzyme catalysis in the presence of ionic liquids

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00124195A EP1205555A1 (en) 2000-11-08 2000-11-08 Enzymatic catalysis in the presence of ionic liquids
EP00124195.9 2000-11-08
PCT/EP2001/012869 WO2002038784A1 (en) 2000-11-08 2001-11-07 Enzyme catalysis in the presence of ionic liquids

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11/440,321 Continuation US20060211096A1 (en) 2000-11-08 2006-05-23 Enzyme catalysis in the presence of ionic liquids

Publications (1)

Publication Number Publication Date
US20040096932A1 true US20040096932A1 (en) 2004-05-20

Family

ID=8170307

Family Applications (3)

Application Number Title Priority Date Filing Date
US10/416,067 Abandoned US20040096932A1 (en) 2000-11-08 2001-11-07 Enzyme catalysis in the presence of ionic liquids
US11/440,321 Abandoned US20060211096A1 (en) 2000-11-08 2006-05-23 Enzyme catalysis in the presence of ionic liquids
US12/119,214 Expired - Fee Related US7754462B2 (en) 2000-11-08 2008-05-12 Enzyme catalysis in the presence of ionic liquids

Family Applications After (2)

Application Number Title Priority Date Filing Date
US11/440,321 Abandoned US20060211096A1 (en) 2000-11-08 2006-05-23 Enzyme catalysis in the presence of ionic liquids
US12/119,214 Expired - Fee Related US7754462B2 (en) 2000-11-08 2008-05-12 Enzyme catalysis in the presence of ionic liquids

Country Status (8)

Country Link
US (3) US20040096932A1 (en)
EP (2) EP1205555A1 (en)
JP (1) JP4195610B2 (en)
AT (1) ATE331803T1 (en)
AU (1) AU2002220685A1 (en)
DE (1) DE50110361D1 (en)
ES (1) ES2267856T3 (en)
WO (1) WO2002038784A1 (en)

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006005409A1 (en) * 2004-07-14 2006-01-19 Degussa Ag Enzymatic reactions in the presence of ionic additives
US20060090271A1 (en) * 2004-11-01 2006-05-04 Price Kenneth N Processes for modifying textiles using ionic liquids
US20060090777A1 (en) * 2004-11-01 2006-05-04 Hecht Stacie E Multiphase cleaning compositions having ionic liquid phase
US20060094616A1 (en) * 2004-11-01 2006-05-04 Hecht Stacie E Ionic liquids derived from surfactants
US20060094620A1 (en) * 2004-11-01 2006-05-04 Jordan Glenn T Iv Compositions containing ionic liquid actives
US20060094621A1 (en) * 2004-11-01 2006-05-04 Jordan Glenn T Iv Process for improving processability of a concentrate and compositions made by the same
US20060094617A1 (en) * 2004-11-01 2006-05-04 Price Kenneth N Benefit agent delivery system comprising ionic liquid
US20060154328A1 (en) * 2003-01-10 2006-07-13 Bruce Neil C Ionic liquids
US20060189499A1 (en) * 2005-02-18 2006-08-24 The Procter & Gamble Company Ionic liquids derived from peracid anions
US20060240728A1 (en) * 2002-06-28 2006-10-26 The Procter & Gamble Company Ionic liquid based products and method of using the same
WO2008009445A1 (en) * 2006-07-21 2008-01-24 Roche Diagnostics Gmbh A reagent for digestion of hemoglobin
US20080274133A1 (en) * 2004-11-18 2008-11-06 Avidex Ltd. Soluble Bifunctional Proteins
US20100081798A1 (en) * 2007-01-23 2010-04-01 Basf Se Method for producing glucose by enzymatic hydrolysis of cellulose that is obtained from material containing ligno-cellulose using an ionic liquid that comprises a polyatomic anion
US20100112646A1 (en) * 2007-01-23 2010-05-06 Basf Se Enzymatic hydrolysis of a cellulose material treated with an ionic liquid
US7737102B2 (en) 2004-11-01 2010-06-15 The Procter & Gamble Company Ionic liquids derived from functionalized anionic surfactants
US8936719B2 (en) 2006-03-22 2015-01-20 Ultraclean Fuel Pty Ltd. Process for removing sulphur from liquid hydrocarbons
US9441169B2 (en) 2013-03-15 2016-09-13 Ultraclean Fuel Pty Ltd Process for removing sulphur compounds from hydrocarbons
US10214697B2 (en) 2013-03-15 2019-02-26 Ultraclean Fuel Pty Limited Process for removing sulphur compounds from hydrocarbons

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10201778A1 (en) * 2002-01-17 2003-07-31 Studiengesellschaft Kohle Mbh Process for carrying out enzymatic reactions in ionic solvents
DE10240098B4 (en) * 2002-08-30 2006-04-06 Roche Diagnostics Gmbh Process for the synthesis and selective biocatalytic modification of peptides, peptide mimetics and proteins
GB0407908D0 (en) * 2004-04-07 2004-05-12 Univ York Ionic liquids
AU2011202949B2 (en) * 2004-04-07 2011-11-24 Worn Again Technologies Limited Ionic liquids comprising nitrogen containing cations
JP2005298404A (en) * 2004-04-12 2005-10-27 Mitsubishi Rayon Co Ltd Method for producing carboxylic acid ester
US20070161095A1 (en) * 2005-01-18 2007-07-12 Gurin Michael H Biomass Fuel Synthesis Methods for Increased Energy Efficiency
DE102007044379A1 (en) 2007-09-17 2009-03-26 Forschungszentrum Jülich GmbH Procedure for the conversion of substrates e.g. organic sulfides, ketones and amino acids, to products by a combined electrochemical and catalytic process in a reaction medium containing ionic liquid`
DE102007058394A1 (en) * 2007-12-03 2009-06-04 Bayer Technology Services Gmbh Process for the production of fuels from biomass
CN102203232A (en) 2008-09-01 2011-09-28 恩维洛维斯科技有限公司 Compositions and methods for the removal of chewing gum residues from substrates
DE102008061866B9 (en) 2008-12-15 2012-12-20 Forschungszentrum Jülich GmbH Use of ionic liquids
JP2017018135A (en) * 2010-07-19 2017-01-26 アルラ フーズ アムバArla Foods Amba Galacto-oligosaccharide-containing composition and method of producing the same
CA2805997A1 (en) * 2010-07-19 2012-01-26 Arla Foods Amba Galacto-oligosaccharide-containing composition and a method of producing it
KR101935367B1 (en) 2012-07-26 2019-01-04 삼성전자주식회사 Method for enhancing efficiency and sensitivity in nucleic acid amplification from biological materials using ionic liquids
CA2921825C (en) * 2013-08-30 2021-07-27 Sekisui Medical Co., Ltd. Method for measuring cholesterol in high-density lipoprotein, and reagent for use in said method
JP7129767B2 (en) * 2016-08-22 2022-09-02 ミヨシ油脂株式会社 Reaction solvent for biocatalyst and method for reacting substrate with biocatalyst using same
CN107937470B (en) * 2017-12-12 2021-03-16 江南大学 Method for synthesizing phytosterol ester in ionic liquid system by enzyme method

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3986930A (en) * 1974-05-28 1976-10-19 Dainippon Pharmaceutical Co., Ltd. Lipase activity determining method and reagent

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3681197A (en) * 1969-01-02 1972-08-01 Clarence T Smith Method and solution for maintaining biological activity in enzymes
SE451849B (en) * 1985-12-11 1987-11-02 Svenska Sockerfabriks Ab VIEW TO SYNTHETIZE GYCLOSIDIC BINDINGS AND USE OF THIS RECEIVED PRODUCTS
KR910008732B1 (en) * 1990-01-22 1991-10-19 한국과학기술 연구원 Process for preparing saccaride derivatives for using reverse hydrolysis of enzyine
EP0968269A4 (en) 1996-10-18 2000-01-05 Procter & Gamble Detergent compositions
JP2000245496A (en) * 1999-03-04 2000-09-12 Meiji Milk Prod Co Ltd Production of fucosyl oligosaccharide

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3986930A (en) * 1974-05-28 1976-10-19 Dainippon Pharmaceutical Co., Ltd. Lipase activity determining method and reagent

Cited By (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080017224A1 (en) * 2002-06-28 2008-01-24 Price Kenneth N Ionic liquid based products and method of using the same
US20060240728A1 (en) * 2002-06-28 2006-10-26 The Procter & Gamble Company Ionic liquid based products and method of using the same
US20060154328A1 (en) * 2003-01-10 2006-07-13 Bruce Neil C Ionic liquids
WO2006005409A1 (en) * 2004-07-14 2006-01-19 Degussa Ag Enzymatic reactions in the presence of ionic additives
US7939485B2 (en) 2004-11-01 2011-05-10 The Procter & Gamble Company Benefit agent delivery system comprising ionic liquid
US7928053B2 (en) 2004-11-01 2011-04-19 The Procter & Gamble Company Multiphase cleaning compositions having ionic liquid phase
US20060094617A1 (en) * 2004-11-01 2006-05-04 Price Kenneth N Benefit agent delivery system comprising ionic liquid
US20060094620A1 (en) * 2004-11-01 2006-05-04 Jordan Glenn T Iv Compositions containing ionic liquid actives
US7776810B2 (en) 2004-11-01 2010-08-17 The Procter & Gamble Company Compositions containing ionic liquid actives
US20060094616A1 (en) * 2004-11-01 2006-05-04 Hecht Stacie E Ionic liquids derived from surfactants
US20060090777A1 (en) * 2004-11-01 2006-05-04 Hecht Stacie E Multiphase cleaning compositions having ionic liquid phase
US20060094621A1 (en) * 2004-11-01 2006-05-04 Jordan Glenn T Iv Process for improving processability of a concentrate and compositions made by the same
US7737102B2 (en) 2004-11-01 2010-06-15 The Procter & Gamble Company Ionic liquids derived from functionalized anionic surfactants
US20090233829A1 (en) * 2004-11-01 2009-09-17 Stacie Ellen Hecht Multiphase cleaning compositions having ionic liquid phase
US7786064B1 (en) 2004-11-01 2010-08-31 The Procter & Gamble Company Ionic liquids derived from functionalized anionic surfactants
US20060090271A1 (en) * 2004-11-01 2006-05-04 Price Kenneth N Processes for modifying textiles using ionic liquids
US20100099314A1 (en) * 2004-11-01 2010-04-22 Stacie Ellen Hecht Ionic liquids derived from surfactants
US20100209991A1 (en) * 2004-11-01 2010-08-19 Stacie Ellen Hecht Ionic liquids derived from functionalized anionic surfactants
US20080274133A1 (en) * 2004-11-18 2008-11-06 Avidex Ltd. Soluble Bifunctional Proteins
US7786065B2 (en) 2005-02-18 2010-08-31 The Procter & Gamble Company Ionic liquids derived from peracid anions
US20060189499A1 (en) * 2005-02-18 2006-08-24 The Procter & Gamble Company Ionic liquids derived from peracid anions
US8936719B2 (en) 2006-03-22 2015-01-20 Ultraclean Fuel Pty Ltd. Process for removing sulphur from liquid hydrocarbons
US20090246814A1 (en) * 2006-07-21 2009-10-01 Uwe Kobold Reagent for digestion of hemoglobin
US7807401B2 (en) 2006-07-21 2010-10-05 Roche Diagnostics Operations, Inc. Reagent for digestion of hemoglobin
WO2008009445A1 (en) * 2006-07-21 2008-01-24 Roche Diagnostics Gmbh A reagent for digestion of hemoglobin
US20100112646A1 (en) * 2007-01-23 2010-05-06 Basf Se Enzymatic hydrolysis of a cellulose material treated with an ionic liquid
US20100081798A1 (en) * 2007-01-23 2010-04-01 Basf Se Method for producing glucose by enzymatic hydrolysis of cellulose that is obtained from material containing ligno-cellulose using an ionic liquid that comprises a polyatomic anion
US8486669B2 (en) 2007-01-23 2013-07-16 Basf Se Enzymatic hydrolysis of a cellulose material treated with an ionic liquid
US9441169B2 (en) 2013-03-15 2016-09-13 Ultraclean Fuel Pty Ltd Process for removing sulphur compounds from hydrocarbons
US10214697B2 (en) 2013-03-15 2019-02-26 Ultraclean Fuel Pty Limited Process for removing sulphur compounds from hydrocarbons

Also Published As

Publication number Publication date
EP1332221A1 (en) 2003-08-06
DE50110361D1 (en) 2006-08-10
WO2002038784B1 (en) 2003-03-20
US20080299623A1 (en) 2008-12-04
JP4195610B2 (en) 2008-12-10
ATE331803T1 (en) 2006-07-15
AU2002220685A1 (en) 2002-05-21
US7754462B2 (en) 2010-07-13
WO2002038784A1 (en) 2002-05-16
US20060211096A1 (en) 2006-09-21
JP2004513639A (en) 2004-05-13
EP1332221B1 (en) 2006-06-28
EP1205555A1 (en) 2002-05-15
ES2267856T3 (en) 2007-03-16

Similar Documents

Publication Publication Date Title
US7754462B2 (en) Enzyme catalysis in the presence of ionic liquids
Park et al. Biocatalysis in ionic liquids–advantages beyond green technology
US7695942B2 (en) Enzymatic conversion of epoxides
JP2691986B2 (en) Process for producing optically active compound having pyridine skeleton
US20060154328A1 (en) Ionic liquids
JPS63273499A (en) Production of optically active compound
Singh et al. Enantioselective transesterification of racemic phenyl ethanol and its derivatives in organic solvent and ionic liquid using Pseudomonas aeruginosa lipase
Jeong et al. Lipase-catalyzed reaction in the packed-bed reactor with continuous extraction column to overcome a product inhibition
EP0529085B1 (en) Process for producing optically active 3-chloro-1-phenyl-1-propanol and derivative thereof
US7005282B2 (en) Enzymes coated with ionic liquid
US5493063A (en) Process for optical resolution of 1,2-diol derivatives
JPS615794A (en) Production of optically active benzyl alcohol derivative
JP4042454B2 (en) Process for producing optically active 3-methylglutaric acid monoester
WO2007071599A2 (en) A process for the production of an optically enriched tertiary alcohol
JP3732535B2 (en) Process for producing optically active α-methylalkanedicarboxylic acid-ω-monoester and its enantiomer diester
KR100337387B1 (en) Method for preparing chiral allyl alcohol
CA2321450A1 (en) Process for producing (r)-2-hydroxy-1-phenoxypropane derivative
KR100567899B1 (en) Method of preparing trans-1S,2S-2-bromo-1-indanyl acetate by enzymatic method
JPH10150998A (en) Production of n-benzyl-3-pyrrolidinol
JP3545442B2 (en) Method for producing optically active 4- (2-halo-1-hydroxyethyl) -2-trifluoromethylthiazole
JP3970898B2 (en) Process for producing optically active α-methylalkanedicarboxylic acid-ω-monoester and its enantiomer diester
EP0148272A1 (en) Process for producing optically active benzyl alcohol compounds
KR100567108B1 (en) Method of preparing trans-1S,2S-1-azido 2-indanol and trans-1R,2R-1-azido 2-indanyl acetate by enzymatic method
Alfani et al. Control of enzyme properties in supramolecular systems
JP3183763B2 (en) Method for producing optically active 1-benzyloxy-2-alkanol

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION